Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/1995
08/03/1995WO1995020568A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
08/03/1995CA2182219A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
08/03/1995CA2182203A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995CA2182198A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
08/03/1995CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995CA2179036A1 Cyanoguanidines as k-channel blockers
08/02/1995EP0665228A1 Pharmaceutical compositions containing 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes
08/02/1995EP0665227A1 Polyhydronorharman synthase inhibitors
08/02/1995EP0665013A1 Method of treating hyperproliferative vascular disease
08/02/1995EP0664814A1 Lipopolysaccharide-binding and neutralizing peptides
08/02/1995EP0664813A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
08/02/1995EP0664808A1 Imidazopyridine derivatives as 5-ht 4? receptor antagonists
08/02/1995EP0664806A1 Heterocyclic condensed benzoic acid derivatives as 5-ht 4? receptor antagonists
08/02/1995EP0664805A1 Heterocyclic -esters or -amides used as 5-ht 4? receptor antagonists
08/02/1995EP0664803A1 N-arylheteroarylalkyl 1-cycloalkyl-imidazol-2-one compounds for treatment of circulatory disorders
08/02/1995EP0664802A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
08/02/1995EP0664801A1 Amide derivatives
08/02/1995EP0664794A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
08/02/1995EP0664711A1 Peptide inhibitors of cellular adhesion
08/02/1995EP0664706A1 Protein kinase c inhibition and novel compound balanol
08/02/1995CN1106013A Therapeutic or preventive agents for diseases associated with peroxyli peroxylipid
08/02/1995CN1106008A 4-aryloxy-and 4-arylthiopiperidine derivatives
08/02/1995CN1106007A Novel sulfonylamino pyrimidines
08/02/1995CN1106003A Inhibitors of microsomal triglyceride transfer protein and method
08/02/1995CN1105993A Preparation of sustituted azole
08/02/1995CN1105990A Phenylalkanolamine derivatives
08/02/1995CN1105989A Tricyclic 1-aminoethylpyrrol derivative
08/02/1995CN1105988A 1-amino-ethylindole-derivatives
08/02/1995CN1105984A Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
08/02/1995CN1105854A Use of benzenesulphonylindole derivatives for the preparation of medicines
08/02/1995CN1029404C Process for preparation of alpha-adrenergic receptor antagonists
08/02/1995CA2141366A1 Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds
08/01/1995US5438118 Peptide mimics having constrained peptide backbone
08/01/1995US5438067 Medetomidine preparations for transdermal administration
08/01/1995US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders
08/01/1995US5438057 Administering a 1,2-bis(3,5-dioxo-4-piperazin-1-yl cyclobutane or-propane for cardioprotection particularly in conjunction with adriamycins
08/01/1995US5438055 Antiarrhythmic benzodiazepines
08/01/1995CA2141231A1 6-azaindole thromboxane synthase inhibitors
08/01/1995CA2140953A1 Polyhydronorharman synthase inhibitors
08/01/1995CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines
08/01/1995CA1336514C Cyclo-octane neuroprotective agents
08/01/1995CA1336505C L-carnitine enriched pet food
07/1995
07/27/1995WO1995019978A1 Tetracyclic derivatives, process of preparation and use
07/27/1995WO1995019968A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
07/27/1995WO1995019961A1 Metalloproteinase inhibitors
07/27/1995WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
07/27/1995WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995WO1995019956A1 Metalloproteinase inhibitors
07/27/1995WO1995019952A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
07/27/1995WO1995019767A1 Guanylhydrazones for treating inflammatory conditions
07/27/1995CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995CA2181581A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
07/27/1995CA2126361A1 Gene encoding cationic amino acid transporter protein
07/26/1995EP0664122A1 Inhibition of imperfect tissue repair
07/26/1995EP0664121A1 Inhibition of ldl oxidation and atherosclerosis
07/26/1995EP0663826A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
07/26/1995EP0663824A1 Potassium channel activating compounds and methods of use thereof
07/26/1995EP0663823A1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
07/26/1995EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
07/26/1995EP0565721B1 1,4-benzothiazepine derivative
07/26/1995EP0416037B1 Superoxide dismutase analogs having novel binding properties
07/25/1995US5436343 Thromboxane A2 receptor antagonist, thromoboxane A2 synthase inhibitor
07/25/1995US5436342 Cardiovascular disorders and muscular disorders
07/25/1995US5436257 Low toxicity
07/25/1995US5436246 Serotonin receptor agents
07/25/1995US5436245 Phosphate substituted amino or imino acids useful as antihypertensives
07/25/1995US5436235 3-aryl-glycidic ester derivatives
07/25/1995US5436233 Nervous system disorders
07/25/1995US5436231 Hypertensive agents
07/25/1995EP0669824A4 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension.
07/25/1995CA2140722A1 Beta-carboline thromboxane synthase inhibitors
07/25/1995CA2140709A1 Substituted arylureas
07/25/1995CA1336433C Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby
07/25/1995CA1336431C Thiazolo(5,4-b)azepine compounds
07/25/1995CA1336429C Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
07/25/1995CA1336428C Substituted dibenzocycloheptenimines
07/25/1995CA1336410C Products containing a calcium antagonist and a lipid-lowering agent
07/20/1995WO1995019436A1 Mammalian monocyte chemoattractant protein receptors
07/20/1995WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/20/1995WO1995019362A1 Dihydro pyrazolopyrroles
07/20/1995WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists
07/20/1995WO1995019183A1 Cd44 expression in smooth muscle cells
07/20/1995WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists
07/20/1995CA2179391A1 Cd44 expression in smooth muscle cells
07/19/1995EP0663406A1 VIP analog
07/19/1995EP0663398A1 Dihydrate of N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-N'-(tetrahydrofuroyl-2)-propylene diamine hydrochloride (= alfuzosin hydrochloride dihydrate) and a process for the preparation
07/19/1995EP0663395A1 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole derivatives, process and intermediates for their preparation and their use as cardiac rhythm reduction agent
07/19/1995EP0663391A1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls
07/19/1995EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof
07/19/1995EP0662975A1 2-substituted adenosines with a-2 receptor affinity.
07/19/1995EP0662971A1 DERIVATIVES OF 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM
07/19/1995EP0662969A1 Urea and thiourea derivatives and process for their preparation
07/19/1995EP0662965A1 1,2-disubstituted ethyl amides as inhibitors of acat
07/19/1995EP0662959A1 5-ht4 antagonists
07/19/1995EP0662950A1 Benzenealkanoic acids for cardiovascular diseases
07/19/1995CN1105362A Methods for lowering serum cholesterol
07/19/1995CN1105361A Methods for exhibiting angiogenisis and angiogenic diseases
07/19/1995CN1105359A Methods for inhibiting smooth muscle cell proliferation and restinosis
1 ... 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 ... 1595